Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CytoDyn Inc. | 4,874,691 | reported | 20 Mar 2026 | tx 2+5,874,691 |
| TuHURA Biosciences, Inc./NV | 156,240 | reported | 12 Feb 2026 | tx 7+1,946,236 |
| Esperion Therapeutics, Inc. | 85,153 | reported | 28 May 2026 | tx 4+132,193 |
| FibroBiologics, Inc. | 22,000 | reported | 12 Jun 2025 | tx 2+27,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Esperion Therapeutics, Inc. | 79,873 | 0.00 USD | |
| 20 Mar 2026 | GRANT_AWARD | CytoDyn Inc. | 4,874,691 | 0.00 USD | deriv |
| 12 Feb 2026 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 156,240 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | FibroBiologics, Inc. | 22,000 | 0.00 USD |
deriv |
| 29 May 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 5,280 | 0.00 USD |
| 29 May 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 7,040 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | CytoDyn Inc. | 1,000,000 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 51,275 | 0.00 USD | deriv |
| 27 Aug 2024 | GRANT_AWARD | FibroBiologics, Inc. | 5,000 | 0.00 USD | deriv |
| 30 Aug 2023 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 23,142 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 59,800 | 0.00 USD |
| 01 Aug 2022 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 400,145 | 0.00 USD |
| 01 Aug 2022 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 1,200,634 | 0.00 USD | deriv |
| 15 Feb 2022 | PURCHASE | TuHURA Biosciences, Inc./NV | 55,000 | 0.47 USD |